Skip to content

Delphi Panel: Next patient populations for manufactured cell-based type 1 diabetes therapy (with / without immunosuppression) (GRA-870)

Delphi Panel: Next patient populations for manufactured cell-based type 1 diabetes therapy (with / without immunosuppression) is a documented award listed in the DePaul Resource Map (starting 2025). Funder: Break Through T1D.

Summary ~

  • Sponsor / funder: Break Through T1D
  • Program: Not specified
  • Status: awarded
  • Period: 2025 – —
  • Lead unit: Not specified
  • Amount: $23,000

Access (availability): 🟢 Green — open or routine · 🟡 Yellow — appointment or affiliation · 🔴 Red — restricted · ⚪/⚫ White/Black — not yet classified

Verification: ✓ confirmed · ~ likely · ? needs review · ✕ archived

Award details

  • Award type: research grant

People

  • Kirsten Yehl (PI)

None documented.

No related outputs documented yet.

No related publications documented yet.

Verification

  • Status: ~ Likely current
  • Notes: Derived from institutional award records.

Sources

Notes

Award metadata compiled from published DePaul research reporting. Listing here records documented activity; it is not an evaluation of the award, the people, or the unit.